TELA Bio, Inc. Quarterly Liabilities, Current in USD from Q4 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: TELA Bio, Inc. quarterly Liabilities, Current history and growth rate from Q4 2018 to Q3 2024.
TELA Bio, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $16.9M, a 9.94% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$16.9M	+$1.52M	+9.94%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$15M	+$1.94M	+14.9%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$15.2M	+$773K	+5.37%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$17M	+$4.56M	+36.8%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$15.3M	+$120K	+0.79%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$13M	+$1.12M	+9.38%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$14.4M	+$2.12M	+17.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$12.4M	+$1.83M	+17.3%	Dec 31, 2022	10-K	2024-03-22
Q3 2022	$15.2M	+$5.84M	+62.2%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$11.9M	+$4.63M	+63.5%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$12.3M	+$6.65M	+118%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$10.6M	+$3.97M	+60.1%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$9.38M	+$4.03M	+75.4%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$7.29M	+$3.67M	+101%	Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$5.64M	+$1.41M	+33.2%	Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$6.61M	-$108K	-1.61%	Dec 31, 2020	10-K	2022-03-23
Q3 2020	$5.35M	-$964K	-15.3%	Sep 30, 2020	10-Q	2020-11-12
Q2 2020	$3.62M			Jun 30, 2020	10-Q	2020-08-13
Q1 2020	$4.23M			Mar 31, 2020	10-Q	2020-05-15
Q4 2019	$6.71M	-$2.85M	-29.8%	Dec 31, 2019	10-K	2021-03-25
Q3 2019	$6.31M			Sep 30, 2019	10-Q	2019-12-18
Q4 2018	$9.56M			Dec 31, 2018	10-K	2020-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.